Efficacy of fetal cardiac axis evaluation in the first trimester as a screening tool for congenital heart defect or aneuploidy

OBJECTIVE: To prove the efficacy of determining the abnormal fetal cardiac axis for screening congenital heart defects (CHDs) and predicting fetal aneuploidy at 11.0 to 13.6 weeks of pregnancy. METHODS: This retrospective study was performed at a single high-risk pregnancy center. The fetal cardiac...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Youn-Joon, Lee, Bo-Ra, Kim, Gwang Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231943/
https://www.ncbi.nlm.nih.gov/pubmed/32489972
http://dx.doi.org/10.5468/ogs.2020.63.3.278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231943/
https://www.ncbi.nlm.nih.gov/pubmed/32489972
http://dx.doi.org/10.5468/ogs.2020.63.3.278

Ejemplares similares